La société DTA Médical, basée à Loulle dans le Jura et dirigée par M. DUFAY François (exposant sélectionné parmi les entreprises innovantes françaises), a gagné le 2ème prix du jury lors des awards remis le 18 novembre dernier à Düsseldorf.
The idea had been cogitating for decades, ever since François Dufay first treated wounds as a young military conscript.
Five years ago he recruited a team of experts and set up DTA Medical to develop Vistacare, an innovative medical device for acute and chronic wound care.
The concept is startling simple: the affected body part is placed in a chamber which delivers and controls, as the skin would, the best conditions for healing: humidity, heat, oxygen, light, pressure and pH balance. However replicating these functions proved difficult, requiring years of intensive R&D.
Today, the Vistacare team considers their device can treat most wounds in 5 to 10 days – significantly faster than treatment with dressings. Vistacare frees the nurse from bandages, reduces pain for the patient, and better preserves the body. Because the affected body part is contained, the risk of germs spreading is greatly limited.
The prototype device treats acute wounds of the lower limb, which represents 90% of the market of acute wounds, but the technology exists to develop devices for other body parts or different types of wounds involving chronic wounds for example. The team is creating a concept of care of wounds from the hospital to the home care. Clinical trials will begin shortly.
At Medica, where DTA MEDICAL is at stand 17D23, the team are looking for distributors and pharmaceutical partners to use active ingredients to be sprayed by the generator into the device. Vistacare is not CE mark (June 2016).